Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 10 results

Search term: MF = 'C_{33}H_{35}F_{2}N_{5}O_{4}'
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
24634193

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C33H35F2N5O4/c1-38(2)23-11-12-26(33(41)42)27(17-23)44-32-29(35)30(40-14-13-24(19-40)39(3)4)28(34)31(37-32)43-25-10-6-9-22(16-25)21-8-5-7-20(15-21)18-36/h5-12,15-17,24H,13-14,18-19,36H2,1-4H3,(H,41,42)
C33H35F2N5O4603.65894300
25056660

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C33H35F2N5O4/c1-38(2)23-11-12-26(33(41)42)27(17-23)44-32-29(35)30(40-14-13-24(19-40)39(3)4)28(34)31(37-32)43-25-10-6-9-22(16-25)21-8-5-7-20(15-21)18-36/h5-12,15-17,24H,13-14,18-19,36H2,1-4H3,(H,41,42)/t24-/m1/s1
C33H35F2N5O4603.65894400
30818529

Double-bond stereo
InChI=1/C33H35F2N5O4/c1-22-11-15-40(16-12-22)14-3-17-43-32-20-28-26(19-31(32)42-2)29(10-13-36-28)44-30-9-8-25(18-27(30)35)38-33(41)39-37-21-23-4-6-24(34)7-5-23/h4-10,13,18-22H,3,11-12,14-17H2,1-2H3,(H2,38,39,41)/b37-21+
C33H35F2N5O4603.65893300
30818537

Double-bond stereo
InChI=1/C33H35F2N5O4/c1-22-11-15-40(16-12-22)14-5-17-43-32-20-28-25(19-31(32)42-2)29(10-13-36-28)44-30-9-8-24(18-27(30)35)38-33(41)39-37-21-23-6-3-4-7-26(23)34/h3-4,6-10,13,18-22H,5,11-12,14-17H2,1-2H3,(H2,38,39,41)/b37-21+
C33H35F2N5O4603.65893300
25045189

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C33H35F2N5O4/c1-4-40(5-2)23-16-17-26(25(19-23)33(41)42)44-32-28(35)29(38-20(3)14-15-21-10-7-6-8-11-21)27(34)31(39-32)43-24-13-9-12-22(18-24)30(36)37/h6-13,16-20H,4-5,14-15H2,1-3H3,(H3,36,37)(H,38,39)(H,41,42)
C33H35F2N5O4603.65893300
9730997
InChI=1/C33H35F2N5O4/c34-26-9-8-24(28(35)15-26)20-39-21-25(19-37-13-10-33(43,11-14-37)22-38-12-4-7-31(38)41)27-16-29(36-17-30(27)39)32(42)40(44)18-23-5-2-1-3-6-23/h1-3,5-6,8-9,15-17,21,43-44H,4,7,10-14,18-20,22H2
C33H35F2N5O4603.65892100
9896083
InChI=1/C33H35F2N5O4/c34-26-9-8-24(28(35)15-26)19-40-20-25(18-38-13-10-33(43,11-14-38)22-39-12-4-7-31(39)41)27-16-29(36-17-30(27)40)32(42)37-44-21-23-5-2-1-3-6-23/h1-3,5-6,8-9,15-17,20,43H,4,7,10-14,18-19,21-22H2,(H,37,42)
C33H35F2N5O4603.65892100
34533277

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C33H35F2N5O4/c34-24-10-8-21(9-11-24)15-39-33(42)44-20-25-19-43-26(16-38-25)12-13-28-29(35)17-37-18-31(28)40-32(41)30(36)14-23-6-3-5-22-4-1-2-7-27(22)23/h1-11,17-18,25-26,30,38H,12-16,19-20,36H2,(H,39,42)(H,40,41)/t25-,26+,30-/m0/s1
C33H35F2N5O4603.65891100
128985052

Double-bond stereo
InChI=1/C33H35F2N5O4/c1-22-11-15-39(16-12-22)14-3-17-43-32-20-28-26(19-31(32)42-2)29(10-13-37-28)44-30-9-8-25(18-27(30)35)40(33(36)41)38-21-23-4-6-24(34)7-5-23/h4-10,13,18-22H,3,11-12,14-17H2,1-2H3,(H2,36,41)/b38-21+
C33H35F2N5O4603.65891100
129189265

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C33H35F2N5O4/c1-22-31(38-16-14-37(15-17-38)18-24-21-43-29-12-5-6-13-30(29)44-24)32(41)40(20-28(36)23-8-3-2-4-9-23)33(42)39(22)19-25-26(34)10-7-11-27(25)35/h2-13,24,28H,14-21,36H2,1H3/t24?,28-/m0/s1
C33H35F2N5O4603.65891100

Advertisement